Data for Looking for changes in lipid levels with knock out of ACADM (shACADM) (part II) (Study ST000819)

(Analysis AN001300)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3
CL 62:1; [M-2H](2-)@5.51 0.5597 1.3449 1.0954
CL 64:1; [M-2H](2-)@9.34 0.9130 0.7899 1.2971
CL 66:1; [M-2H](2-)@9.58 0.9791 1.0132 1.0077
CL 66:2; [M-2H](2-)@9.39 1.0303 0.8286 1.1411
CL 66:3; [M-2H](2-)@5.66 0.4510 1.1703 1.3787
CL 66:3; [M-2H](2-)@9.19 0.9684 0.8277 1.2038
CL 66:4; [M-2H](2-)@8.96 1.3005 0.7709 0.9286
CL 68:1; [M-2H](2-)@9.81 1.0520 0.9181 1.0299
CL 68:2; [M-2H](2-)@9.57 1.1611 0.9100 0.9289
CL 68:3; [M-2H](2-)@9.44 0.9581 0.8851 1.1568
CL 68:4; [M-2H](2-)@9.22 1.0783 0.8384 1.0833
CL 68:5; [M-2H](2-)@9.02 1.0100 0.8971 1.0929
CL 70:1; [M-2H](2-)@6.11 0.8761 1.0226 1.1013
CL 70:2; [M-2H](2-)@9.83 1.1655 0.9224 0.9121
CL 70:3; [M-2H](2-)@9.61 1.1550 0.9131 0.9319
CL 70:4; [M-2H](2-)@9.47 0.9791 0.8845 1.1364
CL 70:5; [M-2H](2-)@9.28 0.8456 1.0190 1.1354
CL 70:6; [M-2H](2-)@9.10 1.1092 0.9590 0.9318
CL 72:2; [M-2H](2-)@10.02 1.2765 1.0042 0.7193
CL 72:3; [M-2H](2-)@9.86 1.0812 0.9750 0.9437
CL 72:4; [M-2H](2-)@9.69 1.1700 0.9073 0.9227
CL 72:5; [M-2H](2-)@9.52 1.0037 0.9753 1.0210
CL 72:6; [M-2H](2-)@9.32 1.0844 0.9551 0.9605
CL 72:7; [M-2H](2-)@9.18 1.1006 0.8984 1.0010
CL 72:8; [M-2H](2-)@8.97 1.1137 0.9542 0.9322
CL 74:11; [M-2H](2-)@5.57 0.7265 1.1171 1.1563
CL 74:1; [M-2H](2-)@6.58 0.8583 1.1139 1.0279
CL 74:5; [M-2H](2-)@9.74 0.9835 0.9940 1.0225
CL 74:6; [M-2H](2-)@9.57 0.9500 0.9362 1.1138
CL 74:7; [M-2H](2-)@6.01 0.8307 0.9873 1.1820
CL 74:7; [M-2H](2-)@9.40 1.2528 0.8905 0.8567
CL 74:9; [M-2H](2-)@5.64 0.7033 0.8712 1.4256
CL 76:8; [M-2H](2-)@9.44 0.9323 0.9005 1.1672
CL 76:9; [M-2H](2-)@9.30 1.1791 0.7689 1.0521
CL 78:11; [M-2H](2-)@9.67 1.6171 0.7727 0.6102
CL 78:13; [M-2H](2-)@5.71 0.8267 0.9357 1.2375
FFA(16:0) 1.0367 1.0274 0.9359
FFA(18:0) 1.0395 1.0312 0.9294
FFA(18:1) 0.9763 0.9638 1.0598
FFA(18:2) 1.1011 0.9675 0.9315
FFA(20:0) 1.0046 1.0473 0.9482
FFA(20:1) 0.9695 0.9246 1.1060
FFA(20:2) 1.0788 0.8760 1.0451
FFA(20:4) Arachidonic acid 1.0141 0.7224 1.2635
FFA(22:0) 0.9130 1.1202 0.9669
FFA(22:1) 1.0828 0.9382 0.9790
FFA(22:2) 0.9950 0.8799 1.1252
FFA(22:3) 0.8875 0.9844 1.1281
FFA(24:0) 1.1237 0.9724 0.9038
FFA(24:1) 1.0017 0.9249 1.0734
FFA(24:2) 1.2971 0.7243 0.9786
FFA(24:3) 1.0419 0.8165 1.1416
lysoPE 18:0; [M-H]-@2.40 0.6557 1.4519 0.8924
lysoPE 20:4; [M-H]-@1.29 1.1946 0.9091 0.8964
lysoPE 20:5; [M-H]-@1.08 1.0376 0.8349 1.1276
lysoPE 22:5; [M-H]-@1.48 1.2147 0.8332 0.9521
lysoPE 22:6; [M-H]-@1.24 1.2221 0.9147 0.8632
PE 32:0; [M-H]-@5.86 1.1930 0.7880 1.0190
PE 32:0; [M-H]-@6.67 0.7637 0.9277 1.3086
PE 33:0; [M-H]-@6.96 0.9795 1.0422 0.9783
PE 33:1; [M-H]-@6.51 0.7554 1.1177 1.1269
PE 34:3; [M-H]-@5.91 0.6446 1.1895 1.1658
PE 34:4; [M-H]-@5.67 0.5153 1.4367 1.0480
PE 35:0; [M-H]-@7.44 0.7543 1.2804 0.9653
PE 35:3; [M-H]-@6.14 0.7606 1.2241 1.0153
PE 36:0; [M-H]-@7.77 1.0647 1.0908 0.8444
PE 36:1; [M-H]-@7.35 0.8718 1.1513 0.9769
PE 36:6; [M-H]-@5.47 0.7688 1.0381 1.1932
PE 37:1; [M-H]-@7.46 0.8868 1.1097 1.0035
PE 37:3; [M-H]-@6.90 1.0187 0.9580 1.0233
PE 37:4; [M-H]-@6.63 0.8840 1.1441 0.9719
PE 38:2; [M-H]-@7.44 0.8749 1.2497 0.8755
PE 38:3; [M-H]-@7.17 0.8273 1.0833 1.0894
PE 38:7; [M-H]-@5.69 0.9131 0.8719 1.2149
PE 39:3; [M-H]-@7.28 1.0901 0.9723 0.9376
PE 39:4; [M-H]-@6.99 0.9574 1.2016 0.8410
PE 39:5; [M-H]-@6.60 0.9835 0.8797 1.1368
PE 39:6; [M-H]-@6.54 0.9348 0.9926 1.0726
PE 40:4; [M-H]-@7.27 1.0925 0.9859 0.9216
PE 40:8; [M-H]-@5.85 0.8834 1.1471 0.9696
PE 42:4; [M-H]-@7.73 0.9374 0.9442 1.1184
PE 42:7; [M-H]-@6.69 0.9776 1.0213 1.0011
PE 44:4; [M-H]-@8.49 1.3659 0.5661 1.0681
PG 32:0; [M-H]-@5.80 1.0617 0.8319 1.1064
PG 32:1; [M-H]-@5.23 0.9661 0.8459 1.1880
PG 33:0; [M-H]-@6.12 1.2252 0.8844 0.8904
PG 33:1; [M-H]-@5.62 1.0650 0.7270 1.2080
PG 34:1; [M-H]-@5.84 1.0264 0.9163 1.0573
PG 34:2; [M-H]-@5.25 0.9917 0.9540 1.0543
PG 34:3; [M-H]-@4.78 0.9191 0.9162 1.1646
PG 36:0; [M-H]-@6.95 0.9905 0.9861 1.0234
PG 36:1; [M-H]-@6.50 0.7615 0.9935 1.2450
PG 36:2; [M-H]-@5.70 0.8170 1.0321 1.1509
PG 36:3; [M-H]-@5.28 1.2339 0.8285 0.9376
PG 36:4; [M-H]-@4.89 1.2946 0.8457 0.8597
PG 36:5; [M-H]-@4.52 0.9980 0.8397 1.1622
PG 38:2; [M-H]-@6.63 0.8372 0.9770 1.1857
PG 38:3; [M-H]-@5.87 1.0996 0.9090 0.9914
PG 38:4; [M-H]-@5.53 0.8867 1.0617 1.0516
PG 38:5; [M-H]-@5.11 1.1345 0.8776 0.9879
PG 38:6; [M-H]-@4.81 1.1876 0.8141 0.9983
PG 38:7; [M-H]-@4.48 1.1214 0.7982 1.0804
PG 40:5; [M-H]-@5.62 1.5556 0.6793 0.7651
PG 40:6; [M-H]-@5.35 1.3339 0.8421 0.8239
PG 40:7; [M-H]-@5.05 0.9252 0.8754 1.1995
PG 40:8; [M-H]-@4.72 1.2596 0.8484 0.8920
PG 42:10; [M-H]-@4.63 1.1006 0.8114 1.0880
PG 42:7; [M-H]-@5.48 1.1319 0.5879 1.2803
PG 42:8; [M-H]-@5.32 1.2530 0.7069 1.0401
PG 42:9; [M-H]-@4.90 0.9586 0.9206 1.1208
PG 44:10; [M-H]-@5.16 1.3790 0.5958 1.0252
PG 44:11; [M-H]-@4.92 1.3952 0.5297 1.0751
PG 44:12; [M-H]-@4.58 1.0704 0.8974 1.0321
PG 44:9; [M-H]-@5.42 1.3217 0.7993 0.8790
PI 32:0; [M-H]-@5.63 0.9702 0.9582 1.0716
PI 32:1; [M-H]-@5.15 0.7297 0.9474 1.3229
PI 34:1; [M-H]-@5.73 1.0069 0.9708 1.0224
PI 34:2; [M-H]-@5.31 0.8437 1.1283 1.0281
PI 36:1; [M-H]-@6.35 0.8376 1.1502 1.0122
PI 36:2; [M-H]-@5.91 1.2155 0.8974 0.8870
PI 36:3; [M-H]-@5.51 0.9022 0.9523 1.1455
PI 36:4; [M-H]-@5.28 0.9566 0.8295 1.2139
PI 38:3; [M-H]-@6.15 0.9905 1.0239 0.9857
PI 38:4; [M-H]-@5.81 0.9383 1.0371 1.0246
PI 38:5; [M-H]-@5.46 0.8816 0.9497 1.1687
PI 38:6; [M-H]-@5.14 0.8020 0.8187 1.3793
PI 40:4; [M-H]-@6.34 0.9011 0.8497 1.2493
PI 40:5; [M-H]-@5.98 0.9909 1.0409 0.9681
PI 40:6; [M-H]-@5.82 1.0332 1.0729 0.8939
plasmenyl-PE 30:0; [M-H]-@6.40 1.2062 0.9608 0.8329
plasmenyl-PE 31:0; [M-H]-@6.62 1.0911 1.0175 0.8914
plasmenyl-PE 33:0; [M-H]-@7.17 1.1641 0.9241 0.9118
plasmenyl-PE 36:0; [M-H]-@8.08 0.9876 1.0132 0.9992
plasmenyl-PE 36:2; [M-H]-@7.24 0.9203 1.0626 1.0171
plasmenyl-PE 38:0; [M-H]-@8.50 0.7507 1.2102 1.0391
plasmenyl-PE 38:1; [M-H]-@8.11 0.9101 1.1272 0.9627
plasmenyl-PE 38:2; [M-H]-@7.74 0.8321 1.0621 1.1058
plasmenyl-PE 38:3; [M-H]-@7.44 1.0516 1.0194 0.9290
plasmenyl-PE 38:4; [M-H]-@7.17 0.9245 1.0149 1.0606
plasmenyl-PE 38:5; [M-H]-@6.70 1.1377 0.8541 1.0082
plasmenyl-PE 38:6; [M-H]-@6.50 1.1341 0.7645 1.1014
plasmenyl-PE 40:1; [M-H]-@8.54 0.8527 1.0452 1.1022
plasmenyl-PE 40:4; [M-H]-@7.60 0.9160 1.0346 1.0494
plasmenyl-PE 40:6; [M-H]-@7.12 0.8890 0.9782 1.1327
plasmenyl-PE 42:4; [M-H]-@8.00 1.1028 0.9809 0.9163
plasmenyl-PE 42:5; [M-H]-@7.81 1.0703 1.0527 0.8770
plasmenyl-PE 42:6; [M-H]-@7.69 0.9763 1.1054 0.9183
PS 32:1; [M-H]-@5.25 0.7254 1.0541 1.2205
PS 34:1; [M-H]-@5.89 0.7735 1.1503 1.0762
PS 34:2; [M-H]-@5.41 0.9561 1.1698 0.8741
PS 36:1; [M-H]-@6.43 0.8493 1.1025 1.0482
PS 36:2; [M-H]-@5.93 0.9603 1.0942 0.9454
PS 36:3; [M-H]-@5.65 1.1248 1.0320 0.8432
PS 36:4; [M-H]-@5.38 0.9682 0.8036 1.2282
PS 38:2; [M-H]-@6.56 0.7998 1.1362 1.0640
PS 38:3; [M-H]-@6.24 0.8928 1.1309 0.9763
PS 38:4; [M-H]-@5.94 0.7534 1.2144 1.0322
PS 38:5; [M-H]-@5.48 1.0335 0.9247 1.0418
PS 38:6; [M-H]-@5.28 0.8962 1.1852 0.9186
PS 40:1; [M-H]-@7.52 0.8611 1.1640 0.9750
PS 40:2; [M-H]-@7.04 1.0068 0.9527 1.0406
PS 40:4; [M-H]-@6.44 1.0034 0.9937 1.0029
PS 40:5; [M-H]-@6.08 1.0074 0.9505 1.0421
PS 40:6; [M-H]-@5.89 0.8120 1.1128 1.0752
PS 42:1; [M-H]-@8.04 0.9086 0.7679 1.3235
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Transduced with:shACADM4
F2Transduced with:shACADM6
F3Transduced with:shACADMscr
  logo